Executive Summary There are a range of benefits in using an integrated supplier to streamline biologic drug development starting in early phase through clinical and commercial stages. Partnering with one supplier that understands how to best...

Improvements in raw material inputs are necessary in order to deploy cell & gene therapies economically and at scale. Watch an on-demand webinar featuring Avantor experts to learn about challenges associated with using non-GMP raw materials, as...
Read more ...

The pandemic challenged the global supply chain instantly. Geopolitical tensions and the call for localizations and self-reliance are further adding to the complexity of today’s API souring. In this article we look on supply chain security in a...
Read more ...

Cambrex eBook: The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021, driven by positive industry trends — many of which our experts commented on in Part 1 of the Cambrex eBook. Market data shows just how...
Read more ...
Page 1 of 2